The effects of inhibitors of RNA and DNA synthesis on protein synthesis and polysome levels in mouse L-cells.
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002499:Centrifugation, Density Gradient; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects*; D003609:Dactinomycin / Q000494:pharmacology*; D003839:Deoxyadenosines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006918:Hydroxyurea / Q000494:pharmacology*; D007700:Kinetics; D007739:L Cells / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010443:Peptide Chain Termination, Translational / Q000187:drug effects; D010761:Phosphorus Radioisotopes; D011132:Polyribosomes / Q000187:drug effects*; D014176:Protein Biosynthesis / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis* / Q000378:metabolism; D012335:RNA, Ribosomal / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium
D001562:Benzimidazoles; D003839:Deoxyadenosines; D010761:Phosphorus Radioisotopes; D011725:Pyridines; D012335:RNA, Ribosomal; D013438:Sulfhydryl Compounds; D003561:Cytarabine; D014316:Tritium; D003609:Dactinomycin; D012313:RNA; D004247:DNA; D003513:Cycloheximide; D006918:Hydroxyurea